Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Immuno-PET Imaging of Engineered Human T Cells in Tumors

Sabine Mall, Nahid Yusufi, Ricarda Wagner, Richard Klar, Henrique Bianchi, Katja Steiger, Melanie Straub, Stefan Audehm, Iina Laitinen, Michaela Aichler, Christian Peschel, Sibylle Ziegler, Mona Mustafa, Markus Schwaiger, Calogero D'Alessandria, Angela M. Krackhardt

Cancer Res (2016) 76 (14): 4113–4123.

https://doi.org/10.1158/0008-5472.CAN-15-2784

Published: 14 July 2016

View article titled, Immuno-PET Imaging of Engineered Human T Cells in Tumors

Includes: Supplementary data

Journal Articles

FLT-PET Is Superior to FDG-PET for Very Early Response Prediction in NPM-ALK-Positive Lymphoma Treated with Targeted Therapy

Zhoulei Li, Nicolas Graf, Ken Herrmann, Alexandra Jünger, Michaela Aichler, Annette Feuchtinger, Anja Baumgart, Axel Walch, Christian Peschel, Markus Schwaiger, Andreas Buck, Ulrich Keller, Tobias Dechow

Cancer Res (2012) 72 (19): 5014–5024.

https://doi.org/10.1158/0008-5472.CAN-12-0635

Published: 30 September 2012

View article titled, FLT-PET Is Superior to FDG-PET for Very Early Response Prediction in NPM-ALK-Positive Lymphoma Treated with Targeted Therapy

Includes: Supplementary data

Journal Articles

Abstract 1887: Targeting oncoprotein stability overcomes lapatinib-resistance due to ERBB2 kinase domain mutations

Rama Krishna Kancha, Franziska Blaeschke, Natalie Bartosch, Christian Peschel, Justus Duyster

Cancer Res (2012) 72 (8_Supplement): 1887.

https://doi.org/10.1158/1538-7445.AM2012-1887

Published: 15 April 2012

View article titled, Abstract 1887: Targeting oncoprotein stability overcomes lapatinib-resistance due to ERBB2 kinase domain mutations

Journal Articles

Stromal Niche Cells Protect Early Leukemic FLT3-ITD⁺ Progenitor Cells against First-Generation FLT3 Tyrosine Kinase Inhibitors

Amanda Parmar, Stefanie Marz, Sally Rushton, Christina Holzwarth, Katarina Lind, Sabine Kayser, Konstanze Döhner, Christian Peschel, Robert A.J. Oostendorp, Katharina S. Götze

Cancer Res (2011) 71 (13): 4696–4706.

https://doi.org/10.1158/0008-5472.CAN-10-4136

Published: 30 June 2011

View article titled, Stromal Niche Cells Protect Early Leukemic FLT3-ITD<sup>+</sup> Progenitor Cells against First-Generation FLT3 Tyrosine Kinase Inhibitors

Includes: Supplementary data

Journal Articles

ADAM17 Regulates Epidermal Growth Factor Receptor Expression through the Activation of Notch1 in Non–Small Cell Lung Cancer

Anja Baumgart, Stefan Seidl, Petros Vlachou, Lars Michel, Nadya Mitova, Nicole Schatz, Katja Specht, Ina Koch, Tibor Schuster, Rebekka Grundler, Marcus Kremer, Falko Fend, Jens T. Siveke, Christian Peschel, Justus Duyster, Tobias Dechow

Cancer Res (2010) 70 (13): 5368–5378.

https://doi.org/10.1158/0008-5472.CAN-09-3763

Published: 30 June 2010

View article titled, ADAM17 Regulates Epidermal Growth Factor Receptor Expression through the Activation of Notch1 in Non–Small Cell Lung Cancer

Includes: Supplementary data

Journal Articles

Antifungal Therapy with Itraconazole Impairs the Anti-Lymphoma Effects of Rituximab by Inhibiting Recruitment of CD20 to Cell Surface Lipid Rafts

Ingo Ringshausen, Yvonne Feuerstacke, Philipp Krainz, Jürgen den Hollander, Ken Hermann, Andreas Buck, Christian Peschel, Christian Meyer zum Bueschenfelde

Cancer Res (2010) 70 (11): 4292–4296.

https://doi.org/10.1158/0008-5472.CAN-10-0259

Published: 01 June 2010

View article titled, Antifungal Therapy with Itraconazole Impairs the Anti-Lymphoma Effects of Rituximab by Inhibiting Recruitment of CD20 to Cell Surface Lipid Rafts

Journal Articles

Abstract 19: Identification of a novel mode of kinase inhibitor resistance: An F604S exchange in FIP1L1-PDGFRA modulates FIP1L1-PDGFRA protein stability in a SHP-2 and SRC-dependent manner

Gorantla P. Sivahari, Nikolas Von Bubnoff, Ana Lena Illert, Nicolas Schneider, Christian Peschel, Justus Duyster

Cancer Res (2010) 70 (8_Supplement): 19.

https://doi.org/10.1158/1538-7445.AM10-19

Published: 15 April 2010

View article titled, Abstract 19: Identification of a novel mode of kinase inhibitor resistance: An F604S exchange in FIP1L1-PDGFRA modulates FIP1L1-PDGFRA protein stability in a SHP-2 and SRC-dependent manner

Journal Articles

Abstract #1766: Study of transforming potential and drug sensitivity of ErbB2 variants identifies lapatinib-resistant kinase domain mutations

Ramakrishna Kancha, Nikolas Bubnoff, Christian Peschel, Justus Duyster

Cancer Res (2009) 69 (9_Supplement): 1766.

Published: 01 May 2009

View article titled, Abstract #1766: Study of transforming potential and drug sensitivity of ErbB2 variants identifies lapatinib-resistant kinase domain mutations

Journal Articles

FMS-Like Tyrosine Kinase 3–Internal Tandem Duplication Tyrosine Kinase Inhibitors Display a Nonoverlapping Profile of Resistance Mutations In vitro

Nikolas von Bubnoff, Richard A. Engh, Espen Åberg, Jana Sänger, Christian Peschel, Justus Duyster

Cancer Res (2009) 69 (7): 3032–3041.

https://doi.org/10.1158/0008-5472.CAN-08-2923

Published: 01 April 2009

View article titled, FMS-Like Tyrosine Kinase 3–Internal Tandem Duplication Tyrosine Kinase Inhibitors Display a Nonoverlapping Profile of Resistance Mutations <em>In vitro</em>

Includes: Supplementary data

Journal Articles

GM1 Expression of Non-Hodgkin's Lymphoma Determines Susceptibility to Rituximab Treatment

Christian Meyer zum Büschenfelde, Yvonne Feuerstacke, Katharina S. Götze, Katrin Scholze, Christian Peschel

Cancer Res (2008) 68 (13): 5414–5422.

https://doi.org/10.1158/0008-5472.CAN-07-5601

Published: 01 July 2008

View article titled, GM1 Expression of Non-Hodgkin's Lymphoma Determines Susceptibility to Rituximab Treatment

Journal Articles

Differential effect of gefitinib and erlotinib on epidermal growth factor receptor mutations observed in NSCLC

Rama Kancha, Nikolas Bubnoff, Christian Peschel, Justus Duyster

Cancer Res (2007) 67 (9_Supplement): 4019.

Published: 01 May 2007

View article titled, Differential effect of gefitinib and erlotinib on epidermal growth factor receptor mutations observed in NSCLC

Journal Articles

A cell-based screening strategy predicts Bcr-Abl mutations that cause resistance toward the second-generation Abl kinase inhibitor AMN107

Nikolas Von Bubnoff, Paul Manley, Doriano Fabbro, Jana Sanger, Christian Peschel, Justus Duyster

Cancer Res (2005) 65 (9_Supplement): 1408.

Published: 01 May 2005

View article titled, A cell-based screening strategy predicts Bcr-Abl mutations that cause resistance toward the second-generation Abl kinase inhibitor AMN107

Journal Articles

Inhibition of Wild-Type and Mutant Bcr-Abl by Pyrido-Pyrimidine-Type Small Molecule Kinase Inhibitors

Nikolas von Bubnoff, Darren R. Veach, W. Todd Miller, Wanqing Li, Jana Sänger, Christian Peschel, William G. Bornmann, Bayard Clarkson, Justus Duyster

Cancer Res (2003) 63 (19): 6395–6404.

Published: 14 October 2003

View article titled, Inhibition of Wild-Type and Mutant Bcr-Abl by Pyrido-Pyrimidine-Type Small Molecule Kinase Inhibitors

Journal Articles

Antihuman Epidermal Growth Factor Receptor 2 (HER2) Monoclonal Antibody Trastuzumab Enhances Cytolytic Activity of Class I-restricted HER2-specific T Lymphocytes Against HER2-overexpressing Tumor Cells

Christian Meyer zum Büschenfelde, Christine Hermann, Burkhard Schmidt, Christian Peschel, Helga Bernhard

Cancer Res (2002) 62 (8): 2244–2247.

Published: 01 April 2002

View article titled, Antihuman Epidermal Growth Factor Receptor 2 (HER2) Monoclonal Antibody Trastuzumab Enhances Cytolytic Activity of Class I-restricted HER2-specific T Lymphocytes Against HER2-overexpressing Tumor Cells

NARROW

Immuno-PET Imaging of Engineered Human T Cells in Tumors

FLT-PET Is Superior to FDG-PET for Very Early Response Prediction in NPM-ALK-Positive Lymphoma Treated with Targeted Therapy

Abstract 1887: Targeting oncoprotein stability overcomes lapatinib-resistance due to ERBB2 kinase domain mutations

Stromal Niche Cells Protect Early Leukemic FLT3-ITD⁺ Progenitor Cells against First-Generation FLT3 Tyrosine Kinase Inhibitors

ADAM17 Regulates Epidermal Growth Factor Receptor Expression through the Activation of Notch1 in Non–Small Cell Lung Cancer

Antifungal Therapy with Itraconazole Impairs the Anti-Lymphoma Effects of Rituximab by Inhibiting Recruitment of CD20 to Cell Surface Lipid Rafts

Abstract 19: Identification of a novel mode of kinase inhibitor resistance: An F604S exchange in FIP1L1-PDGFRA modulates FIP1L1-PDGFRA protein stability in a SHP-2 and SRC-dependent manner

Abstract #1766: Study of transforming potential and drug sensitivity of ErbB2 variants identifies lapatinib-resistant kinase domain mutations

FMS-Like Tyrosine Kinase 3–Internal Tandem Duplication Tyrosine Kinase Inhibitors Display a Nonoverlapping Profile of Resistance Mutations In vitro

GM1 Expression of Non-Hodgkin's Lymphoma Determines Susceptibility to Rituximab Treatment

Differential effect of gefitinib and erlotinib on epidermal growth factor receptor mutations observed in NSCLC

A cell-based screening strategy predicts Bcr-Abl mutations that cause resistance toward the second-generation Abl kinase inhibitor AMN107

Inhibition of Wild-Type and Mutant Bcr-Abl by Pyrido-Pyrimidine-Type Small Molecule Kinase Inhibitors

Antihuman Epidermal Growth Factor Receptor 2 (HER2) Monoclonal Antibody Trastuzumab Enhances Cytolytic Activity of Class I-restricted HER2-specific T Lymphocytes Against HER2-overexpressing Tumor Cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only